DJIA 16,486.58 -15.07 -0.09%
NASDAQ 4,141.37 14.40 0.35%
S&P 500 1,877.33 1.94 0.10%
market minute promo

292.82 -10.26 (-3.39%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $292.82 -3.39%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $305.77
Previous Close $303.08
Daily Range $291.59 - $306.70
52-Week Range $206.30 - $352.49
Market Cap $29.3B
P/E Ratio 79.55
Dividend (Yield) $0.00 (0.0%)
Volume 657,818
Average Daily Volume 1,142,777
Current FY EPS $4.38





Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog

3 Drugs Stocks Dragging The Industry Down

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog

Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog

Why Biogen (BIIB) Stock Is Down Today

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

3 Stocks Reiterated As A Hold: PM, FSLR, REGN

Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner

Nasdaq 100 Movers: LLTC, YHOO

See More REGN News...

REGN's Top Competitors

REGN $292.82 (-3.39%)
Current stock: REGN
AMGN $113.97 (0.58%)
Current stock: AMGN
GILD $73.79 (-0.09%)
Current stock: GILD
BIIB $294.03 (-4.15%)
Current stock: BIIB